Posts in Core Rigor and Reproducibility (CoRRe)

Dear Frances,
I am interested. What I have to provide you?


Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Clinical  Research Committee 2
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://5/1> Room 1SCR4.3015
Houston- TX 77054<x-apple-data-detectors://7/0>
T  713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>

Sent from my iPhone

On May 21, 2019, at 6:59 AM, Weis-Garcia, Frances/Sloan Kettering Institute
<email obscured><email obscured>>>
wrote:

WARNING: This email originated from outside of MD Anderson. Please validate the
sender's email address before clicking on links or attachments as they may not
be safe.

Dear Rohitash,



In the past you had indicated interest in being an Association of Biomolecular
Research Facilities (ABRF) Technical Reviewers.  We are forwarding a list of
reviewers onto the Journal of Cell Biology (JCB) editor soon and would like to
know if you are still open to serving as an ABRF Technical Reviewer.
Participation is a one of several member benefits. Others include, but are not
limited to, driving Research Group Studies and a discounted registration at our
annual meeting.  Should you be interested in learning more, please reach out to
the ABRF Committee for Core Rigor and Reproducibility (CCoRRe) for details
about this initiative to promote well documented research or the ABRF
Membership Committee about how membership in our professional society can
benefit your career.  If you are not interested, we would also like to learn
why so we can make informed decisions as to how ABRF could better serve our
peers moving forward.



Looking forward to hearing from you and have a great week.



Sincerely,



Rebecca Davies                   University of Minnesota

Nancy Fisher                         University of North Carolina School of
Medicine

Chris Gregory                      University of North Carolina School of
Medicine

Adrian Halme                       University of Virginia School of Medicine

Kevin Knudtson                    University of Iowa (Executive Board Liaison)

Susan Meyn                          Vanderbilt University Medical Center
(Chair)

Sheenah Mische                  NYU School of Medicine

Katia Sol Church                  University of Virginia School of Medicine

Frances Weis-Garcia           Memorial Sloan Kettering Cancer Center


――
View topic http://list.abrf.org/r/topic/JXn5pCJVRAMQBvq7TihOJ
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

Dear John,



In the past you had indicated interest in being an Association of Biomolecular
Research Facilities (ABRF) Technical Reviewers.  We are forwarding a list of
reviewers onto the Journal of Cell Biology (JCB) editor soon and would like to
know if you are still open to serving as an ABRF Technical Reviewer.
Participation is a one of several member benefits. Others include, but are not
limited to, driving Research Group Studies and a discounted registration at our
annual meeting.  Should you be interested in learning more, please reach out to
the ABRF Committee for Core Rigor and Reproducibility (CCoRRe) for details
about this initiative to promote well documented research or the ABRF
Membership Committee about how membership in our professional society can
benefit your career.  If you are not interested, we would also like to learn
why so we can make informed decisions as to how ABRF could better serve our
peers moving forward.



Looking forward to hearing from you and have a great week.



Sincerely,



Rebecca Davies                   University of Minnesota

Nancy Fisher                         University of North Carolina School of
Medicine

Chris Gregory                      University of North Carolina School of
Medicine

Adrian Halme                       University of Virginia School of Medicine

Kevin Knudtson                    University of Iowa (Executive Board Liaison)

Susan Meyn                          Vanderbilt University Medical Center
(Chair)

Sheenah Mische                  NYU School of Medicine

Katia Sol Church                  University of Virginia School of Medicine

Frances Weis-Garcia           Memorial Sloan Kettering Cancer Center

Dear Javier,



In the past you had indicated interest in being an Association of Biomolecular
Research Facilities (ABRF) Technical Reviewers.  We are forwarding a list of
reviewers onto the Journal of Cell Biology (JCB) editor soon and would like to
know if you are still open to serving as an ABRF Technical Reviewer.
Participation is a one of several member benefits. Others include, but are not
limited to, driving Research Group Studies and a discounted registration at our
annual meeting.  Should you be interested in learning more, please reach out to
the ABRF Committee for Core Rigor and Reproducibility (CCoRRe) for details
about this initiative to promote well documented research or the ABRF
Membership Committee about how membership in our professional society can
benefit your career.  If you are not interested, we would also like to learn
why so we can make informed decisions as to how ABRF could better serve our
peers moving forward.



Looking forward to hearing from you and have a great week.



Sincerely,



Rebecca Davies                   University of Minnesota

Nancy Fisher                         University of North Carolina School of
Medicine

Chris Gregory                      University of North Carolina School of
Medicine

Adrian Halme                       University of Virginia School of Medicine

Kevin Knudtson                    University of Iowa (Executive Board Liaison)

Susan Meyn                          Vanderbilt University Medical Center
(Chair)

Sheenah Mische                  NYU School of Medicine

Katia Sol Church                  University of Virginia School of Medicine

Frances Weis-Garcia           Memorial Sloan Kettering Cancer Center

Dear Pierre-Alain,



In the past you had indicated interest in being an Association of Biomolecular
Research Facilities (ABRF) Technical Reviewers.  We are forwarding a list of
reviewers onto the Journal of Cell Biology (JCB) editor soon and would like to
know if you are still open to serving as an ABRF Technical Reviewer.
Participation is a one of several member benefits. Others include, but are not
limited to, driving Research Group Studies and a discounted registration at our
annual meeting.  Should you be interested in learning more, please reach out to
the ABRF Committee for Core Rigor and Reproducibility (CCoRRe) for details
about this initiative to promote well documented research or the ABRF
Membership Committee about how membership in our professional society can
benefit your career.  If you are not interested, we would also like to learn
why so we can make informed decisions as to how ABRF could better serve our
peers moving forward.



Looking forward to hearing from you and have a great week.



Sincerely,



Rebecca Davies                   University of Minnesota

Nancy Fisher                         University of North Carolina School of
Medicine

Chris Gregory                      University of North Carolina School of
Medicine

Adrian Halme                       University of Virginia School of Medicine

Kevin Knudtson                    University of Iowa (Executive Board Liaison)

Susan Meyn                          Vanderbilt University Medical Center
(Chair)

Sheenah Mische                  NYU School of Medicine

Katia Sol Church                  University of Virginia School of Medicine

Frances Weis-Garcia           Memorial Sloan Kettering Cancer Center

Thanks for sharing Ken.

-----Original Message-----
From: "Core Rigor and Reproducibility (CoRRe)" <email obscured>> on behalf
of Ken Schoppmann <email obscured>>
Reply-To: <email obscured>>
Date: Friday, May 3, 2019 at 3:48 PM
To: <email obscured>>
Subject: [core rigor and reproducibility (corre)] Register Now: May 7 National
Academies Report Release Webinar on Reproducibility and Replicability in
Science


    Public Release Webinar
    Reproducibility and Replicability in Science

    May 7, 2019 | 1:00 PM EDT

    Register here:
https://nasem.zoom.us/webinar/register/WN_3OXr2pQfS0SRfd_pmCGH7w?utm_source=NASEM+News+and+Publications&utm_campaign=9109fe56fc-Reproducibility_Webinar_2019_05_02&utm_medium=email&utm_term=0_96101de015-9109fe56fc-102633401&goal=0_96101de015-9109fe56fc-102633401&mc_cid=9109fe56fc&mc_eid=1793eeac3d

    Please join us for a public webinar to learn about the new National
Academies' report Reproducibility and Replicability in Science. The webinar
will include an overview of the study process and discussion of the report’s
conclusions, recommendations, and key messages.

    Speakers will include:
    HARVEY V. FINEBERG (Chair), Gordon and Betty Moore Foundation
    LORENA A. BARBA, George Washington University
    JULIANA FREIRE, New York University
    CONSTANTINE GATSONIS, Brown University
    DIETRAM A. SCHEUFELE, University of Wisconsin

    ――
    View topic http://list.abrf.org/r/topic/558nm4fZQZSD4JbGsnM1QO
    Leave group <email obscured>?Subject=Unsubscribe

We have something similar already specific to Flow Cytometry. It is the
'MIFlowCyt' standard, which stands for Minimum Information about a Flow
Cytometry experiment. It recommends transparency in reporting technical detail,
reagent information and data analysis. Papers published with this information
in Cytometry Part A get the MIFlowCyt badge.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773297/

FASEB invites their conference attendees to participate in their badge program,
indicating key factors for research rigor:

http://www.faseb.org/Science-Research-Conferences/Transparency-and-Rigor-Initiative.aspx

Hi Brian,
 I found this very old document. It should be an update I guess because for
other policies are updates every year or so.
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-99-005.html
Let me know if this is useful. When I search for cDNA other documents pop-up
but more specific such as for Zebrafish or profiling the nervous system. They
look more like protocols or rules. And being so old (1999), several things
could change.
Sorry, I didn't read in more details and I apologize if it is not what you are
looking for.
Thanks!
Laura

Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Clinical  Research Committee 2
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St Room 1SCR4.3015
Houston- TX 77054
T  713-563-3301 <tel:713-563-3301>
F 713-563-3276 <tel:713-563-3276>
<email obscured>



On 4/24/19, 5:52 AM, "Brian Hampton" <email obscured>> wrote:

    WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.

    Hello all,

    Is there a resource that details what journals or funding agencies require
for publishing data that utilizes cDNA clones?  I've done a brief search of
various journal's instructions for authors and came up empty.

    I am surprised that I haven't easily found at least minimal requirements to
submit as supplementary or to make available upon request, the data that proves
that the cDNA used in the experiments has the correct/desired nucleotide
sequence.

    Given the fundamental role of the cDNA cloned into expression vectors have
in so many experimental approaches which are used to determine the function of
gene products in biological processes, I would think that it should be an
explicit requirement to provide this basic evidence - that what you are
transfecting into cells is what you say it is.

    Thanks in advance for any input,

    Brian
    ――
    View topic http://list.abrf.org/r/topic/5oCYrBWBqFrMNw68F3WItO
    Leave group <email obscured>?Subject=Unsubscribe



The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

That is great Roy!



Would love to know more about where their interests lie and ours align.  I
organized a session on antibody validation with Anthony Couvillon from CST at
NERDS last year because I respect them so much.



From: Roy Martin <email obscured>>
Date: Monday, April 1, 2019 at 3:12 PM
To: Frances Weis-Garcia <email obscured>>
Cc: Andy Chitty <email obscured>>, "Core Rigor and Reproducibility (CoRRe)"
<email obscured>>, Education Committee <email obscured>>, Philip E
Hockberger <email obscured>>
Subject: Re: Reproducibility - Online Education - Cell Signalling Technology



Thanks for this Frances,

I had a long talk with Kim Lee and Chuck Farnsworth from CST last week about
their involvement with ABRF, and have some notes and insight if it helps. I
think, or maybe hope, that they'll be contacting the ABRF directly (ED or EB)
or perhaps through the CRC/CAC with more direct feedback.

Roy







From:        "Weis-Garcia, Frances/Sloan Kettering Institute"
<email obscured>>
To:        "Core Rigor and Reproducibility (CoRRe)" <email obscured>>,
Education Committee <email obscured>>, Philip E Hockberger
<email obscured>>
Cc:        Andy Chitty <email obscured>>
Date:        04/01/2019 09:27 AM
Subject:        Reproducibility - Online Education - Cell Signalling Technology




Dear CCoRRe, EdComm and Phil,

FYI - I share the following as food for thought not only because it traverses
the areas of reproducibility and online education, topics near and dear to our
ABRF hearts, but also because CST wanted to run a SW before ABRF2019 and may be
open to the idea this year.

https://www.prweb.com/releases/cell_press_and_cell_signaling_technology_launch_online_resource_to_help_scientists_achieve_experimental_and_career_success/prweb16183745.htm

ATLANTA (PRWEB) March 31, 2019

Today, at the American Association of Cancer Research conference, Cell Press, a
leading publisher of over 40 primary research and review journals, and Cell
Signaling Technology (CST), a leading provider of antibodies, kits, and
services, are excited to announce a new educational resource that will make it
easier for biology students and researchers to navigate their careers, get
published, and strengthen their laboratory skills to enable experimental
success. The new resource is entitled Cell Mentor™.
https://www.cell.com/cell-mentor#gt

CST appears to be providing all the “Get Technical” track of this 4 track
initiative.  If CellPress is getting content from others with their brand, then
this may be an way for us to get it online as well … with links on our website
of course.

Frances



--
You received this message because you are subscribed to the Google Groups
"EdComm" group.
To unsubscribe from this group and stop receiving emails from it, send an email
to <email obscured>.
To post to this group, send email to <email obscured>.
For more options, visit https://groups.google.com/a/my.abrf.org/d/optout.

The information in this email is confidential, and is intended solely for the
addressee(s). Access to this email by anyone else is unauthorized and therefore
prohibited. If you are not the intended recipient you are notified that
disclosing, copying, distributing or taking any action in reliance on the
contents of this information is strictly prohibited and may be unlawful.

Thanks

-----Original Message-----
From: "Core Rigor and Reproducibility (CoRRe)" <email obscured>> on behalf
of ncfisher <email obscured>>
Reply-To: <email obscured>>
Date: Tuesday, March 19, 2019 at 4:05 PM
To: <email obscured>>
Subject: [core rigor and reproducibility (corre)] Rigor and Reproducibility
sessions at ABRF

    Don't miss:

    Sunday, March 24th, 6:30 - 7:30pm
    Henry B. González Convention Center, Room 214D
    The Antibody Crisis: Leveraging machine learning for evidence-based
antibody search

    Monday, March 25, 4:30 - 5:30  Room 214ABC
    Rigor and Reproducibility Practices in a Core Setting
    Featuring:
    Kevin Knudston, Susan Meyn, Ian Sullivan, Stephen Uebel

    ――
    View topic http://list.abrf.org/r/topic/7LDViRRXPQTqHOGbPhu2ae
    Leave group <email obscured>?Subject=Unsubscribe